Cite
HARVARD Citation
Lukin, D. et al. (2019). Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. Inflammatory bowel diseases. 25 (4), pp. 775-781. [Online].